Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyotrophic Lateral Sclerosis | 77 | 2024 | 1484 | 12.900 |
Why?
|
Phenylbutyrates | 5 | 2024 | 72 | 3.170 |
Why?
|
Motor Neuron Disease | 7 | 2022 | 98 | 2.530 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2020 | 35 | 1.410 |
Why?
|
Uric Acid | 6 | 2023 | 809 | 1.290 |
Why?
|
Neuroprotective Agents | 4 | 2022 | 959 | 1.110 |
Why?
|
Neurodegenerative Diseases | 7 | 2023 | 1087 | 1.100 |
Why?
|
Low Back Pain | 3 | 2019 | 987 | 1.040 |
Why?
|
Electrodiagnosis | 2 | 2018 | 149 | 0.940 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 500 | 0.890 |
Why?
|
Evidence-Based Medicine | 7 | 2021 | 3685 | 0.880 |
Why?
|
Shoulder Pain | 2 | 2018 | 152 | 0.880 |
Why?
|
Exercise Therapy | 3 | 2020 | 937 | 0.860 |
Why?
|
Disease Progression | 18 | 2024 | 13632 | 0.800 |
Why?
|
Telemedicine | 7 | 2020 | 3105 | 0.730 |
Why?
|
Patient Education as Topic | 3 | 2021 | 2334 | 0.720 |
Why?
|
Muscle Stretching Exercises | 1 | 2020 | 37 | 0.690 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 7425 | 0.610 |
Why?
|
Teaching Materials | 1 | 2018 | 85 | 0.580 |
Why?
|
Videoconferencing | 1 | 2019 | 209 | 0.540 |
Why?
|
Humans | 126 | 2024 | 765968 | 0.510 |
Why?
|
Clinical Trials as Topic | 10 | 2023 | 8041 | 0.500 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 4 | 2009 | 43 | 0.500 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 271 | 0.500 |
Why?
|
Myositis, Inclusion Body | 1 | 2017 | 145 | 0.500 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2018 | 260 | 0.490 |
Why?
|
Double-Blind Method | 11 | 2024 | 12437 | 0.470 |
Why?
|
Burnout, Professional | 4 | 2024 | 711 | 0.470 |
Why?
|
Neuromuscular Diseases | 1 | 2017 | 261 | 0.470 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 533 | 0.460 |
Why?
|
Robotics | 4 | 2023 | 809 | 0.460 |
Why?
|
Porphyrias | 1 | 2014 | 55 | 0.460 |
Why?
|
Brachial Plexus Neuritis | 1 | 2014 | 20 | 0.450 |
Why?
|
Myositis | 1 | 2017 | 270 | 0.450 |
Why?
|
Motor Skills | 1 | 2017 | 516 | 0.440 |
Why?
|
Median Nerve | 1 | 2014 | 132 | 0.430 |
Why?
|
Biological Products | 1 | 2022 | 942 | 0.420 |
Why?
|
Nervous System Diseases | 3 | 2020 | 1660 | 0.400 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3850 | 0.400 |
Why?
|
Neuroglia | 1 | 2017 | 964 | 0.380 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 452 | 0.350 |
Why?
|
Middle Aged | 44 | 2024 | 223009 | 0.350 |
Why?
|
Motor Neurons | 6 | 2021 | 869 | 0.340 |
Why?
|
Job Satisfaction | 2 | 2024 | 549 | 0.340 |
Why?
|
Osteoma, Osteoid | 1 | 2011 | 94 | 0.340 |
Why?
|
Internship and Residency | 2 | 2021 | 5946 | 0.320 |
Why?
|
Aged | 33 | 2024 | 171117 | 0.320 |
Why?
|
Adult | 41 | 2024 | 223044 | 0.320 |
Why?
|
Research | 1 | 2017 | 1975 | 0.310 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2268 | 0.310 |
Why?
|
Male | 53 | 2024 | 363698 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2005 | 1624 | 0.300 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3100 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3223 | 0.300 |
Why?
|
Astrocytes | 4 | 2018 | 1345 | 0.300 |
Why?
|
Muscular Diseases | 1 | 2012 | 550 | 0.300 |
Why?
|
Machado-Joseph Disease | 1 | 2008 | 26 | 0.290 |
Why?
|
Female | 49 | 2024 | 396112 | 0.290 |
Why?
|
DNA Repeat Expansion | 1 | 2008 | 74 | 0.280 |
Why?
|
Synapses | 2 | 2009 | 1754 | 0.270 |
Why?
|
Electromyography | 4 | 2018 | 1399 | 0.270 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 543 | 0.270 |
Why?
|
Research Design | 2 | 2022 | 6209 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2019 | 5370 | 0.260 |
Why?
|
Survival Analysis | 6 | 2023 | 10070 | 0.260 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15880 | 0.250 |
Why?
|
Spastic Paraplegia, Hereditary | 2 | 2021 | 172 | 0.250 |
Why?
|
Wnt Proteins | 1 | 2009 | 722 | 0.250 |
Why?
|
Bibliometrics | 2 | 2019 | 357 | 0.250 |
Why?
|
Neurofilament Proteins | 2 | 2024 | 337 | 0.250 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 784 | 0.250 |
Why?
|
United States Food and Drug Administration | 2 | 2024 | 1672 | 0.240 |
Why?
|
Activities of Daily Living | 7 | 2023 | 2415 | 0.240 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2817 | 0.230 |
Why?
|
Hexosaminidases | 1 | 2024 | 45 | 0.230 |
Why?
|
Ambulatory Care Facilities | 3 | 2021 | 939 | 0.230 |
Why?
|
Football | 2 | 2021 | 504 | 0.230 |
Why?
|
Neural Conduction | 2 | 2018 | 444 | 0.230 |
Why?
|
Hippocampus | 2 | 2009 | 3775 | 0.220 |
Why?
|
Shoulder Joint | 1 | 2011 | 740 | 0.220 |
Why?
|
Travel | 2 | 2020 | 806 | 0.220 |
Why?
|
Genetic Counseling | 1 | 2008 | 634 | 0.220 |
Why?
|
Dyslipidemias | 1 | 2011 | 869 | 0.220 |
Why?
|
Body Mass Index | 2 | 2012 | 13039 | 0.220 |
Why?
|
Spinal Cord | 3 | 2021 | 1784 | 0.210 |
Why?
|
United States | 16 | 2024 | 72903 | 0.210 |
Why?
|
Vitamin D | 1 | 2017 | 3272 | 0.210 |
Why?
|
Hand | 3 | 2020 | 909 | 0.210 |
Why?
|
Qualitative Research | 2 | 2024 | 3139 | 0.210 |
Why?
|
Radiculopathy | 2 | 2018 | 205 | 0.210 |
Why?
|
Linoleic Acids | 1 | 2022 | 39 | 0.200 |
Why?
|
Neurites | 1 | 2005 | 389 | 0.200 |
Why?
|
CD40 Ligand | 1 | 2024 | 528 | 0.200 |
Why?
|
Neurons | 3 | 2009 | 9525 | 0.200 |
Why?
|
Riluzole | 1 | 2022 | 62 | 0.200 |
Why?
|
Inosine | 1 | 2023 | 129 | 0.200 |
Why?
|
Drugs, Investigational | 1 | 2024 | 211 | 0.200 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6547 | 0.190 |
Why?
|
Curriculum | 3 | 2021 | 3782 | 0.190 |
Why?
|
Brain | 7 | 2021 | 27171 | 0.190 |
Why?
|
Spinal Cord Injuries | 2 | 2020 | 927 | 0.190 |
Why?
|
Sex Characteristics | 1 | 2012 | 2643 | 0.190 |
Why?
|
Esters | 1 | 2022 | 214 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 12240 | 0.180 |
Why?
|
Quality of Life | 8 | 2022 | 13462 | 0.180 |
Why?
|
Glycosylation | 1 | 2004 | 1100 | 0.180 |
Why?
|
Patient Care Team | 3 | 2019 | 2517 | 0.180 |
Why?
|
Phenylenediamines | 1 | 2021 | 89 | 0.170 |
Why?
|
Huntington Disease | 1 | 2007 | 1147 | 0.170 |
Why?
|
Quality Improvement | 3 | 2020 | 3853 | 0.170 |
Why?
|
Administration, Inhalation | 2 | 2023 | 1154 | 0.170 |
Why?
|
Lower Extremity | 2 | 2021 | 1226 | 0.170 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5508 | 0.170 |
Why?
|
Elbow Joint | 1 | 2023 | 357 | 0.170 |
Why?
|
Home Care Services | 2 | 2020 | 660 | 0.160 |
Why?
|
Cromolyn Sodium | 1 | 2019 | 76 | 0.160 |
Why?
|
Antioxidants | 2 | 2018 | 1670 | 0.160 |
Why?
|
Industry | 1 | 2021 | 362 | 0.160 |
Why?
|
Carbamates | 1 | 2021 | 191 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 416 | 0.160 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2020 | 102 | 0.160 |
Why?
|
Cytoskeleton | 1 | 2004 | 1178 | 0.160 |
Why?
|
Cooking | 1 | 2021 | 327 | 0.160 |
Why?
|
Receptors, GABA | 2 | 2018 | 312 | 0.160 |
Why?
|
Endpoint Determination | 1 | 2022 | 591 | 0.160 |
Why?
|
Time | 1 | 2020 | 550 | 0.150 |
Why?
|
Pyrazines | 1 | 2024 | 1204 | 0.150 |
Why?
|
Wheelchairs | 2 | 2020 | 78 | 0.150 |
Why?
|
Imidazoles | 1 | 2024 | 1162 | 0.150 |
Why?
|
Sick Leave | 1 | 2019 | 105 | 0.150 |
Why?
|
Geographic Information Systems | 1 | 2020 | 280 | 0.150 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2567 | 0.150 |
Why?
|
Pamphlets | 1 | 2018 | 71 | 0.150 |
Why?
|
Baseball | 1 | 2019 | 95 | 0.150 |
Why?
|
Computers, Handheld | 1 | 2020 | 211 | 0.150 |
Why?
|
Enteral Nutrition | 3 | 2020 | 803 | 0.150 |
Why?
|
Fatty Acids | 2 | 2023 | 1806 | 0.150 |
Why?
|
Caregivers | 4 | 2019 | 2307 | 0.150 |
Why?
|
Proportional Hazards Models | 4 | 2023 | 12509 | 0.140 |
Why?
|
Behavior | 1 | 2020 | 535 | 0.140 |
Why?
|
Education, Distance | 1 | 2021 | 262 | 0.140 |
Why?
|
Interneurons | 1 | 2002 | 593 | 0.140 |
Why?
|
Adaptation, Psychological | 2 | 2021 | 2660 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 4392 | 0.140 |
Why?
|
Time Factors | 7 | 2023 | 40065 | 0.140 |
Why?
|
Cost of Illness | 2 | 2019 | 1950 | 0.140 |
Why?
|
Survival | 1 | 2017 | 160 | 0.140 |
Why?
|
Athletes | 2 | 2021 | 1162 | 0.130 |
Why?
|
Acetamides | 1 | 2018 | 260 | 0.130 |
Why?
|
Myofibrils | 1 | 2017 | 143 | 0.130 |
Why?
|
Sodium Chloride | 1 | 2018 | 576 | 0.130 |
Why?
|
Survival Rate | 3 | 2017 | 12795 | 0.130 |
Why?
|
Review Literature as Topic | 1 | 2018 | 297 | 0.130 |
Why?
|
Running | 1 | 2021 | 488 | 0.130 |
Why?
|
Rehabilitation | 1 | 2017 | 125 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1957 | 0.130 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 266 | 0.130 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2108 | 0.130 |
Why?
|
Benzothiazoles | 1 | 2016 | 246 | 0.120 |
Why?
|
Muscle Weakness | 2 | 2019 | 413 | 0.120 |
Why?
|
Shoulder | 1 | 2017 | 297 | 0.120 |
Why?
|
Arm | 2 | 2023 | 589 | 0.120 |
Why?
|
Pandemics | 5 | 2022 | 8703 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 65188 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10729 | 0.120 |
Why?
|
Central Nervous System | 1 | 2002 | 1341 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1240 | 0.120 |
Why?
|
Physicians | 2 | 2023 | 4588 | 0.120 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2015 | 164 | 0.120 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2014 | 43 | 0.110 |
Why?
|
Tracheostomy | 2 | 2019 | 429 | 0.110 |
Why?
|
Housing | 1 | 2019 | 683 | 0.110 |
Why?
|
Muscle Strength | 1 | 2018 | 637 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10383 | 0.110 |
Why?
|
Drug Combinations | 1 | 2020 | 2077 | 0.110 |
Why?
|
Vital Capacity | 3 | 2024 | 995 | 0.110 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2229 | 0.110 |
Why?
|
Cost Savings | 1 | 2019 | 904 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3672 | 0.110 |
Why?
|
Self-Help Devices | 1 | 2014 | 62 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1396 | 0.110 |
Why?
|
Patient Selection | 3 | 2021 | 4255 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 927 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 12976 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1668 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 36532 | 0.110 |
Why?
|
Hospice Care | 1 | 2020 | 678 | 0.110 |
Why?
|
Orthotic Devices | 1 | 2014 | 131 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 81514 | 0.110 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2014 | 116 | 0.100 |
Why?
|
Ganglion Cysts | 1 | 2012 | 27 | 0.100 |
Why?
|
Terminal Care | 2 | 2015 | 1774 | 0.100 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2012 | 43 | 0.100 |
Why?
|
Animals | 11 | 2022 | 168764 | 0.100 |
Why?
|
Ulnar Neuropathies | 1 | 2012 | 32 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3607 | 0.100 |
Why?
|
Biomedical Research | 3 | 2024 | 3458 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 59889 | 0.100 |
Why?
|
Psychotic Disorders | 1 | 2007 | 3270 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 1005 | 0.100 |
Why?
|
Publishing | 1 | 2019 | 835 | 0.100 |
Why?
|
Parkinson Disease | 3 | 2017 | 2895 | 0.100 |
Why?
|
Pilot Projects | 3 | 2021 | 8733 | 0.090 |
Why?
|
Complementary Therapies | 1 | 2015 | 487 | 0.090 |
Why?
|
Ambulatory Care | 2 | 2019 | 2778 | 0.090 |
Why?
|
Polyneuropathies | 1 | 2012 | 139 | 0.090 |
Why?
|
Counseling | 1 | 2019 | 1551 | 0.090 |
Why?
|
Wrist | 1 | 2012 | 231 | 0.090 |
Why?
|
Educational Measurement | 1 | 2018 | 1260 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9249 | 0.090 |
Why?
|
Thiazolidinediones | 1 | 2013 | 459 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2018 | 1051 | 0.090 |
Why?
|
Pyridines | 2 | 2021 | 2888 | 0.090 |
Why?
|
Muscular Dystrophies | 1 | 2012 | 392 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1808 | 0.080 |
Why?
|
Acceleration | 1 | 2011 | 187 | 0.080 |
Why?
|
Pain Measurement | 1 | 2020 | 3561 | 0.080 |
Why?
|
Neck | 1 | 2014 | 733 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2018 | 18973 | 0.080 |
Why?
|
Dermatomyositis | 1 | 2012 | 261 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2499 | 0.080 |
Why?
|
Motor Cortex | 2 | 2017 | 1003 | 0.080 |
Why?
|
Databases, Factual | 2 | 2017 | 8067 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5302 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2021 | 5767 | 0.080 |
Why?
|
Personal Satisfaction | 2 | 2023 | 641 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1462 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2014 | 598 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39193 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2009 | 245 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2410 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2904 | 0.070 |
Why?
|
Registries | 2 | 2021 | 8297 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2012 | 1206 | 0.070 |
Why?
|
Monitoring, Ambulatory | 1 | 2011 | 357 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3251 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1432 | 0.070 |
Why?
|
Single-Blind Method | 2 | 2023 | 1589 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3141 | 0.070 |
Why?
|
Dendrites | 1 | 2009 | 469 | 0.070 |
Why?
|
Cell Line | 3 | 2018 | 15543 | 0.070 |
Why?
|
Walking | 1 | 2014 | 1198 | 0.070 |
Why?
|
Actigraphy | 1 | 2011 | 532 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 54802 | 0.070 |
Why?
|
Physical Examination | 1 | 2012 | 1266 | 0.070 |
Why?
|
Mice | 7 | 2019 | 81819 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15398 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3615 | 0.060 |
Why?
|
Hand Strength | 2 | 2020 | 462 | 0.060 |
Why?
|
Accidental Falls | 1 | 2014 | 1078 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2798 | 0.060 |
Why?
|
Prognosis | 2 | 2017 | 29922 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2024 | 2354 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2007 | 15747 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2011 | 642 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6322 | 0.060 |
Why?
|
Data Collection | 3 | 2020 | 3318 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4209 | 0.060 |
Why?
|
Stress Fibers | 1 | 2004 | 55 | 0.060 |
Why?
|
RNA, Untranslated | 1 | 2008 | 453 | 0.060 |
Why?
|
Hydrazones | 1 | 2024 | 105 | 0.060 |
Why?
|
Phalloidine | 1 | 2003 | 21 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4863 | 0.050 |
Why?
|
Pediatrics | 1 | 2019 | 3606 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2011 | 1129 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4058 | 0.050 |
Why?
|
Torque | 1 | 2023 | 132 | 0.050 |
Why?
|
Cohort Studies | 5 | 2021 | 41649 | 0.050 |
Why?
|
Biotinylation | 1 | 2003 | 184 | 0.050 |
Why?
|
Elbow | 1 | 2023 | 129 | 0.050 |
Why?
|
Dystroglycans | 1 | 2002 | 62 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2002 | 107 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4958 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2003 | 528 | 0.050 |
Why?
|
Receptors, Neurotransmitter | 1 | 2002 | 171 | 0.050 |
Why?
|
Incidence | 4 | 2022 | 21480 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2005 | 462 | 0.050 |
Why?
|
Point Mutation | 1 | 2007 | 1590 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2023 | 226 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12056 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2004 | 11022 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 577 | 0.050 |
Why?
|
Butyrates | 1 | 2022 | 162 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 791 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3110 | 0.040 |
Why?
|
Ciprofloxacin | 1 | 2022 | 314 | 0.040 |
Why?
|
Comorbidity | 1 | 2015 | 10563 | 0.040 |
Why?
|
Presynaptic Terminals | 1 | 2002 | 297 | 0.040 |
Why?
|
Immunoblotting | 1 | 2003 | 1644 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 538 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59489 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2001 | 255 | 0.040 |
Why?
|
Israel | 1 | 2022 | 725 | 0.040 |
Why?
|
Tubulin | 1 | 2003 | 692 | 0.040 |
Why?
|
Adolescent | 4 | 2021 | 88835 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1066 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2020 | 160 | 0.040 |
Why?
|
Vitamin E | 1 | 2024 | 869 | 0.040 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2019 | 14 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2709 | 0.040 |
Why?
|
Pyrimidines | 2 | 2024 | 3047 | 0.040 |
Why?
|
Palliative Care | 1 | 2014 | 3645 | 0.040 |
Why?
|
Mastication | 1 | 2019 | 53 | 0.040 |
Why?
|
Psychological Tests | 1 | 2021 | 644 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2004 | 12768 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4108 | 0.040 |
Why?
|
Morphogenesis | 1 | 2002 | 744 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 22223 | 0.040 |
Why?
|
Microtubules | 1 | 2004 | 1062 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14071 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 663 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 677 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 291 | 0.040 |
Why?
|
Cadherins | 1 | 2002 | 900 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 1673 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2788 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 796 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 2021 | 494 | 0.030 |
Why?
|
Neuromuscular Junction | 1 | 2019 | 396 | 0.030 |
Why?
|
Risk Factors | 3 | 2021 | 74840 | 0.030 |
Why?
|
Spirometry | 1 | 2020 | 929 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2018 | 522 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9591 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2002 | 1325 | 0.030 |
Why?
|
Actins | 1 | 2004 | 2056 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13266 | 0.030 |
Why?
|
Movement | 2 | 2015 | 1462 | 0.030 |
Why?
|
Equipment Design | 2 | 2017 | 3481 | 0.030 |
Why?
|
Certification | 1 | 2019 | 416 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4562 | 0.030 |
Why?
|
RNA Interference | 1 | 2005 | 2832 | 0.030 |
Why?
|
Telephone | 1 | 2019 | 627 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2002 | 1612 | 0.030 |
Why?
|
Alleles | 1 | 2007 | 6897 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2002 | 3089 | 0.030 |
Why?
|
Bradycardia | 1 | 2017 | 302 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2022 | 1896 | 0.030 |
Why?
|
Axons | 1 | 2003 | 1682 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 990 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5747 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2143 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 811 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 576 | 0.030 |
Why?
|
Levodopa | 1 | 2015 | 222 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1635 | 0.030 |
Why?
|
Antiparkinson Agents | 1 | 2015 | 185 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1831 | 0.030 |
Why?
|
Signal Transduction | 2 | 2009 | 23601 | 0.030 |
Why?
|
Speech | 1 | 2019 | 555 | 0.030 |
Why?
|
Glutamine | 1 | 2017 | 576 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2033 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 906 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18293 | 0.030 |
Why?
|
Decision Making | 2 | 2019 | 3965 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2615 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2021 | 806 | 0.030 |
Why?
|
Child | 2 | 2019 | 80564 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2014 | 234 | 0.020 |
Why?
|
Advance Care Planning | 1 | 2019 | 702 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2194 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3690 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4331 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2017 | 1180 | 0.020 |
Why?
|
Athletic Injuries | 1 | 2021 | 1240 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2021 | 1921 | 0.020 |
Why?
|
PPAR gamma | 1 | 2013 | 483 | 0.020 |
Why?
|
Italy | 1 | 2012 | 854 | 0.020 |
Why?
|
Clothing | 1 | 2011 | 95 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1549 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 9747 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1432 | 0.020 |
Why?
|
Metabolomics | 1 | 2019 | 1668 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3315 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9649 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3770 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3111 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3708 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 834 | 0.020 |
Why?
|
Rats | 1 | 2004 | 23707 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20124 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20659 | 0.020 |
Why?
|
Phenotype | 1 | 2005 | 16721 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5089 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9601 | 0.020 |
Why?
|
Apoptosis | 1 | 2001 | 9514 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7421 | 0.010 |
Why?
|
Anxiety | 1 | 2019 | 4671 | 0.010 |
Why?
|
Brain Mapping | 1 | 2018 | 6601 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11888 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10850 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10603 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8923 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22332 | 0.010 |
Why?
|
Replication Origin | 1 | 2001 | 78 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2001 | 238 | 0.010 |
Why?
|
Simian virus 40 | 1 | 2001 | 290 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 258 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2001 | 858 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8237 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 13076 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2001 | 473 | 0.010 |
Why?
|
Clone Cells | 1 | 2001 | 1672 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26318 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14652 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2001 | 1158 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14751 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30198 | 0.010 |
Why?
|
Down-Regulation | 1 | 2001 | 2927 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15652 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5743 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5786 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11641 | 0.000 |
Why?
|